T80/A5/H12.5 mg FDC tablet

DRUG2 trials

Sponsors

Boehringer Ingelheim

Conditions

Healthy

Phase 1

Bioequivalence Study of Telmisartan Between T80/A5/H12.5 mg FDC Tablet and T80/A5 mg Tab and H12.5 mg Tab Concomitant Use

CompletedNCT02121535

Boehringer IngelheimHealthy

Start: 2014-04-30End: 2014-08-31Updated: 2017-04-12

Bioequivalence Study of Telmisartan Between Telmisartan 80 mg/Amlodipine 5 mg/Hydrochlorothiazide 12.5 mg (T80/A5/H12.5 mg) Fixed-dose Combination (FDC) Tablet and T80/H12.5 mg Tab and A5 mg (Encap A2.5 mg Tab x2) Concomitant Use

CompletedNCT02129192

Boehringer IngelheimHealthy

Start: 2014-05-31End: 2014-09-30Updated: 2017-04-12